Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD

FHS
January 6, 2025
11:02 am

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD exacerbations and pneumonia risk.

Sen. Feinstein Falls; Maui Hospitals Overwhelmed; CDC’s New COVID Leader

Note that some links may require registration or subscription. Sen. Dianne Feinstein (D) of California is recovering after being briefly hospitalized after a fall in

August 11, 2023

Sunscreen prototype keeps skin cooler and shields from UV rays

Wearing sunscreen is important to protect your skin from the harmful effects of UV radiation but doesn’t cool people off.

December 19, 2024

Continuous Parkinson’s Disease Therapy Wins FDA Nod

The FDA approved a subcutaneous 24-hour continuous infusion of foscarbidopa and foslevodopa (Vyalev) for advanced Parkinson’s disease, AbbVie announced Thursday. Foscarbidopa and foslevodopa are pro-drugs

October 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.